CV
AERI

Clarus Ventures’s Aerie Pharmaceuticals AERI Stock Holding History

Clarus Ventures’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-63,017
Closed -$1.53M – 7
2015
Q4 		$1.53M Hold
63,017
– – 1.08% 7
2015
Q3 		$1.12M Buy
+63,017
New +$1.14M 0.64% 8
2015
Q1 		– Sell
-3,338,067
Closed -$97.4M – 8
2014
Q4 		$97.4M Sell
3,338,067
-130,428
-4% -$3.31M 27.82% 1
2014
Q3 		$71.8M Hold
3,468,495
– – 28.63% 1
2014
Q2 		$85.9M Hold
3,468,495
– – 30.5% 1
2014
Q1 		$73.5M Hold
3,468,495
– – 21.27% 3
2013
Q4 		$62.3M Buy
+3,468,495
New +$45.2M 17.6% 3

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return